AAP
CDNA icon

Ardsley Advisory Partners’s CareDx CDNA Stock Holding History

Ardsley Advisory Partners’s Portfolio CDNA Stock Details CDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-20,000
Closed -$147K – 147
2017
Q4 		$147K Buy
+20,000
New +$125K 0.02% 130

Other funds holding CDNA

FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
NCGI
Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
GA
Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return
PWP
Private Wealth Partners Mill Valley, California $1.3B AUM 26.2% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ardsley Advisory Partners's CDNA Position: Q1 2018 in Review

Ardsley Advisory Partners sold out of CareDx (CDNA) in Q1 2018, closing a stake of 20,000 shares — an estimated $147K sold.

Ardsley Advisory Partners first reported a position in CDNA in Q4 2017 and held it in 1 quarter. The position peaked at $147K in Q4 2017. 73 funds tracked by Wall St. Rank hold CDNA as of Q1 2018.

  • Ardsley Advisory Partners reported no remaining CareDx position as of Q1 2018 after selling out during the quarter.
  • Ardsley Advisory Partners sold 20,000 CareDx shares in Q1 2018, an estimated $147K.
  • Ardsley Advisory Partners first reported a position in CareDx in Q4 2017 and held it in 1 quarter.
  • Ardsley Advisory Partners's CareDx position peaked at $147K in Q4 2017.
  • 73 funds tracked by Wall St. Rank held CareDx as of Q1 2018.

Based on Ardsley Advisory Partners's 13F filing for Q1 2018, filed 15 May 2018.